#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Endometrial adenocarcinoma Prolymphocytic leukaemia Hereditary hypophosphataemic rickets Amyloidosis Cholestatic pruritus Chordoma Thalassaemia alpha Cholangiocarcinoma Retinopathy of prematurity Myotonic dystrophy Gaucher's disease type I VEXAS syndrome Dementia Alzheimer's type Postprandial hypoglycaemia Central nervous system lymphoma More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma stage IV Undifferentiated sarcoma – Diagnostics Castleman’s disease – Life with Disease Haemophilia – Life with Disease Kearns-Sayre syndrome – Basic Information Alport’s syndrome – Diagnostics Rhabdomyosarcoma recurrent – Diagnostics X-linked lymphoproliferative syndrome – Diagnostics Nodal marginal zone B-cell lymphoma – Treatment Epidermolysis bullosa – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Imlifidase Dydrogesterone Modafinil Abc-23A-116 Neob Tocilizumab RPTR-1-201 Rebisufligene Etisparvovec Benfotiamine Terlipressin Efgartigimod Alfa Carvedilol Azithromycin Dextrose Bp Follitropin Alfa Sodium Phosphate Treprostinil Sodium Diphenhydramine Desogestrel Emavusertib More therapies…

    Learn about Your Condition

    Partial lipodystrophy Hypervolaemia Cardiovascular disorder Retinal vein occlusion Vaginal cancer Hypertrophic scar Myeloid leukaemia Chronic coronary syndrome Restless legs syndrome Oesophageal cancer metastatic Acoustic neuroma Cervix carcinoma stage II Anogenital dysplasia Richter's syndrome Endometrial cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier Universitaire Rouen

Centre Hospitalier Universitaire Rouen

1 Rue De Germont, Bp 96031, Rouen, 76031, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Safety and Effectiveness of Acasunlimab and Pembrolizumab for Patients with Recurrent Non-Small Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Acasunlimab
    • Pembrolizumab
    France Germany Italy The Netherlands Poland Portugal +1

  • Study on the Effect of Low-Dose Aspirin in Preventing New or Recurrent Colorectal Polyps in Patients with Lynch Syndrome

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Colorectal adenoma
    • Hereditary non-polyposis colorectal cancer syndrome
    Investigated Drugs:
    • Acetylsalicylic Acid
    France

  • Study on the Effectiveness of Aspirin in Patients with Resected Colon Cancer with PI3K Mutation Stage III or II High Risk

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Colon cancer
    • Colon cancer stage III
    Investigated Drugs:
    • Acetylsalicylic Acid
    France

  • Study on Personalized Treatment for Metastatic Colorectal Cancer Using Regorafenib for Patients with Advanced Disease

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Regorafenib
    France

  • Study on Mepolizumab and Drug Combination for Patients with Eosinophilic Granulomatosis with Polyangiitis

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Azathioprine
    • Cyclophosphamide
    • Mepolizumab
    France

  • Study of Encorafenib and Binimetinib for Patients with BRAFV600E-Mutant Metastatic Non-Small Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage IV
    Investigated Drugs:
    • Binimetinib
    • Encorafenib
    France

  • Study on Reducing Antibiotic Use in Severe COPD Exacerbation with Amoxicillin, Cefotaxime, and Ciprofloxacin for Patients on Mechanical Ventilation or Oxygen Therapy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Amoxicillin Sodium
    • Cefepime Hydrochloride
    • Cefotaxime
    France

  • Study on Barzolvolimab for Patients with Chronic Spontaneous Urticaria Unresponsive to H1 Antihistamines

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Barzolvolimab
    • Epinephrine
    Belgium Bulgaria Czechia Denmark France Germany +5

  • Study of Lutikizumab compared to placebo in adults and adolescents (age 12 and older) with moderate to severe Hidradenitis Suppurativa

    Not recruiting

    3 1
    Investigated Drugs:
    • Lutikizumab
    Austria Belgium Bulgaria Croatia Czechia Denmark +16

  • Study of platinum, pemetrexed, atezolizumab and bevacizumab combination in patients with advanced non-small cell lung cancer who have EGFR, ALK or ROS1 mutations and progressed after targeted therapy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer recurrent
    Investigated Drugs:
    • Atezolizumab
    • Bevacizumab
    • Carboplatin
    France
Previous Page
1 … 34 35 36 37 38 … 48
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!